Hot Pursuit     07-Nov-24
Biocon Ltd up for third consecutive session
Biocon Ltd is quoting at Rs 327, up 1.29% on the day as on 12:49 IST on the NSE. The stock is up 44.15% in last one year as compared to a 24.62% jump in NIFTY and a 45.62% jump in the Nifty Pharma index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 327, up 1.29% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 1.04% on the day, quoting at 24230.1. The Sensex is at 79668.59, down 0.88%. Biocon Ltd has slipped around 4.58% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has slipped around 3.18% in last one month and is currently quoting at 22920.35, down 1.54% on the day. The volume in the stock stood at 15.6 lakh shares today, compared to the daily average of 28.76 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 328.35, up 1.19% on the day. Biocon Ltd is up 44.15% in last one year as compared to a 24.62% jump in NIFTY and a 45.62% jump in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending September 24.

Previous News
  Biocon gains after receiving US FDA approval for type-2 diabetes treatment drug Dapagliflozin
 ( Hot Pursuit - 08-Apr-26   11:05 )
  Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
 ( Corporate News - 08-Apr-26   09:18 )
  Biocon launches biosimilars - Bosaya™ and Aukelso™ in U.S.
 ( Corporate News - 07-Apr-26   19:52 )
  Biocon announces major leadership reshuffle
 ( Hot Pursuit - 27-Mar-26   13:00 )
  Biocon approves change in CFO
 ( Corporate News - 27-Mar-26   12:12 )
  Biocon appoints Shreehas Tambe as CEO and MD
 ( Corporate News - 27-Mar-26   12:03 )
  Biocon board accepts resignation of Siddharth Mittal as CEO and MD
 ( Corporate News - 27-Mar-26   11:58 )
  Biocon gets USFDA nod for Liraglutide injection gVictoza
 ( Hot Pursuit - 13-Mar-26   09:24 )
  Biocon Ltd soars 0.99%, gains for fifth straight session
 ( Hot Pursuit - 25-Feb-26   13:00 )
  Biocon receives USFDA approval for Liraglutide
 ( Corporate News - 25-Feb-26   12:05 )
  Biocon gets US FDA nod for chronic weight management drug Liraglutide
 ( Hot Pursuit - 25-Feb-26   09:42 )
Other Stories
  SJVN ends higher after appointing Parthajit De as CFO
  10-Apr-26   15:50
  IT stocks slide after TCS’ Q4 miss disappoints Street
  10-Apr-26   15:11
  Kesoram Industries Ltd leads losers in 'A' group
  10-Apr-26   15:00
  Inventure Growth & Securities Ltd leads losers in 'B' group
  10-Apr-26   14:45
  IFB Industries gains on appointing Sandeep Joseph Abraham as MD & CEO
  10-Apr-26   14:44
  Niyogin Fintech climbs after strong Q4 performance
  10-Apr-26   14:31
  Volumes spurt at New India Assurance Company Ltd counter
  10-Apr-26   14:30
  Dev IT gains on bagging Rs 26-cr order
  10-Apr-26   13:36
  Siyaram Recycling Industries gains after bagging Rs 2-cr order
  10-Apr-26   13:32
  TVS Motor Company Ltd spurts 2.04%, up for third straight session
  10-Apr-26   13:05
Back Top